FDA Agenda Slates Stevens-Johnson Proposal For June; GMPs In December?
This article was originally published in The Tan Sheet
Executive Summary
FDA intends to issue a proposed rule to add a warning about Stevens-Johnson Syndrome to the NSAID allergy label in June, the agency announces in HHS' semi-annual "unified agenda.